AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 39 filers reported holding AN2 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51 | -77.8% | 3,170 | -88.3% | 0.00% | – |
| Q2 2023 | $230 | -28.8% | 27,074 | -17.4% | 0.00% | – |
| Q1 2023 | $323 | +12.9% | 32,773 | +9.0% | 0.00% | – |
| Q4 2022 | $286 | -99.9% | 30,058 | +10.2% | 0.00% | -100.0% |
| Q3 2022 | $475,000 | +1150.0% | 27,278 | +458.1% | 0.00% | – |
| Q2 2022 | $38,000 | -86.2% | 4,888 | -73.2% | 0.00% | – |
| Q1 2022 | $275,000 | – | 18,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 433,330 | $6,530,000 | 1.89% |
| RA Capital Management | 3,666,663 | $55,257,000 | 1.21% |
| BVF INC/IL | 1,616,665 | $24,363,000 | 0.98% |
| Avidity Partners Management LP | 688,330 | $10,373,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 584,136 | $8,803,000 | 0.20% |
| COWEN AND COMPANY, LLC | 60,278 | $908,000 | 0.09% |
| Woodline Partners LP | 150,000 | $2,261,000 | 0.04% |
| Alyeska Investment Group, L.P. | 125,000 | $1,884,000 | 0.02% |
| Citadel Advisors | 1,419,851 | $20,593,000 | 0.00% |
| Anson Funds Management LP | 2,500 | $38,000 | 0.00% |